Table 3.
Characteristics of the patients (N = 4,946)
| Patients (n = 4,946) | |
|---|---|
| Age (mean, standard deviation) |
43.9 (15.7) |
| > = 55 years (%) |
25.4 |
| Sex ratio (male:female) |
1.3 |
| WHO regions (%) |
|
| Africa |
52.9 |
| America |
0.7 |
| Eastern Europe |
33.8 |
| Pacifica |
1.6 |
| South East Asia |
11.0 |
| Diagnostic: CML (%) |
91.4 |
| Initial Phase (%) |
|
| Chronic |
84.7 |
| Accelerated |
13.3 |
| Blast crisis |
2.0 |
| Status (%) |
|
| Active |
70.5 |
| Closed |
27.5 |
| Denied |
2.0 |
| Duration of follow up (month; mean, standard deviation) | 25.8 (25.9) |